Bank of America
SIOX

Bank of America’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bank of America’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-244
Closed -$106 – 8540
2022
Q4 		$106 Buy
244
+130
+114% +$42 ﹤0.01% 7662
2022
Q3 		$0 Hold
114
– – ﹤0.01% 8416
2022
Q2 		$0 Sell
114
-8,352
-99% -$3.46K ﹤0.01% 8667
2022
Q1 		$6K Sell
8,466
-12,911
-60% -$11K ﹤0.01% 7875
2021
Q4 		$27K Buy
21,377
+119
+0.6% +$211 ﹤0.01% 7438
2021
Q3 		$46K Buy
21,258
+21,238
+106,190% +$46.2K ﹤0.01% 7093
2021
Q2 		$0 Sell
20
-8
-29% -$20 ﹤0.01% 8261
2021
Q1 		$0 Buy
28
+26
+1,300% +$74 ﹤0.01% 7923
2020
Q4 		$0 Sell
2
-175,156
-100% -$510K ﹤0.01% 7476
2020
Q3 		$809K Buy
175,158
+175,156
+8,757,800% +$578K ﹤0.01% 4368
2020
Q2 		$0 Sell
2
-21,696
-100% -$69.6K ﹤0.01% 7244
2020
Q1 		$53K Buy
21,698
+20,244
+1,392% +$73.1K ﹤0.01% 5849
2019
Q4 		$7K Sell
1,454
-47,196
-97% -$262K ﹤0.01% 6718
2019
Q3 		$314K Buy
48,650
+1,423
+3% +$9.81K ﹤0.01% 5385
2019
Q2 		$294K Sell
47,227
-125,576
-73% -$956K ﹤0.01% 5421
2019
Q1 		$1.84M Buy
172,803
+172,794
+1,919,933% +$1.72M ﹤0.01% 4056
2018
Q4 		$0 Sell
9
-24
-73% -$346 ﹤0.01% 7485
2018
Q3 		$0 Sell
33
-2,143
-98% -$39K ﹤0.01% 7541
2018
Q2 		$40K Buy
2,176
+930
+75% +$13.7K ﹤0.01% 6255
2018
Q1 		$14K Sell
1,246
-3,338
-73% -$53.6K ﹤0.01% 6505
2017
Q4 		$193K Sell
4,584
-39,983
-90% -$1.79M ﹤0.01% 5431
2017
Q3 		$2.45M Buy
44,567
+44,091
+9,263% +$7.44M ﹤0.01% 3808
2017
Q2 		$88K Sell
476
-449
-49% -$78.7K ﹤0.01% 5650
2017
Q1 		$111K Buy
925
+259
+39% +$27.1K ﹤0.01% 5573
2016
Q4 		$66K Buy
666
+343
+106% +$36.1K ﹤0.01% 5809
2016
Q3 		$36K Sell
323
-755
-70% -$90.6K ﹤0.01% 5870
2016
Q2 		$111K Buy
1,078
+1,038
+2,595% +$104K ﹤0.01% 5471
2016
Q1 		$4K Sell
40
-3
-7% -$320 ﹤0.01% 6657
2015
Q4 		$6K Sell
43
-259
-86% -$33.7K ﹤0.01% 6842
2015
Q3 		$31K Buy
302
+289
+2,223% +$33.9K ﹤0.01% 6155
2015
Q2 		$2K Buy
+13
New +$2.2K ﹤0.01% 7066

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Bank of America's SIOX Position: Q1 2023 in Review

Bank of America sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 244 shares — an estimated $106 sold.

Bank of America first reported a position in SIOX in Q2 2015 and held it in 31 quarters. The position peaked at $2.45M in Q3 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Bank of America reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 244 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $106.
  • Bank of America first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 31 quarters.
  • Bank of America's Sio Gene Therapies Inc. Common Stock position peaked at $2.45M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.